The pandemic underscored what we already knew to be true for biopharma industry: We need to make therapeutics faster and more affordably.
The field of biopharma has never been more exciting. From radiopharmaceuticals to mRNA to CAR-T, new technologies and modalities offer incredible potential for patients. But pandemic underscored what we already knew to be true for biopharma industry: We need to make therapeutics faster and more affordably.
This eBook will offer insight on:
Today's rising radiopharmaceutical market
mRNA's potential for long-term success
Overcoming manufacturing challenges in adoptive cell therapy
Keeping up-to-date on emergency safety technology
A new approach to cleanrooms
This content is sponsored by Bradley Corporation and Vetter.
